Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Acer Therapeutics reports results from pivotal study of Edsivo in vascular Ehlers-Danlos syndrome

Sep. 27, 2017

Pluristem planning phase III study of PLX-PAD cells for muscle recovery after arthroplasty

Sep. 27, 2017

Medivir reports promising topline data on MIV-711 in knee osteoarthritis

Sep. 27, 2017

Janssen Biotech receives complete response letter for sirukumab BLA

Sep. 26, 2017

ImmuPharma offers update on Lupuzor program

Sep. 26, 2017

NIH grant to support development of Cel-Sci's rheumatoid arthritis vaccine

Sep. 20, 2017

Boehringer Ingelheim receives positive opinion for adalimumab biosimilar Cyltezo

Sep. 18, 2017

Phase III trial of upadacitinib in rheumatoid arthritis meets all endpoints

Sep. 12, 2017

Daiichi Sankyo and Sanford Burnham Prebys begin clinical trial of DS-1211

Sep. 7, 2017

Promising RORgammaT inhibitors discovered at Merck & Co.

Sep. 5, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...